American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention

American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cance...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology Jg. 34; H. 15; S. 1803
Hauptverfasser: Bailey, Howard H, Chuang, Linus T, duPont, Nefertiti C, Eng, Cathy, Foxhall, Lewis E, Merrill, Janette K, Wollins, Dana S, Blanke, Charles D
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 20.05.2016
Schlagworte:
Female
Humans
Medical Oncology
Papillomavirus Vaccines - adverse effects
Papillomavirus Vaccines - immunology
Physician's Role
Societies, Medical
Uterine Cervical Neoplasms - prevention & control
Vaccination
ISSN:1527-7755, 1527-7755
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:American Society of Clinical Oncology (ASCO), the leading medical professional oncology society, is committed to lessening the burden of cancer and as such will promote underused interventions that have the potential to save millions of lives through cancer prevention. As the main providers of cancer care worldwide, our patients, their families, and our communities look to us for guidance regarding all things cancer related, including cancer prevention. Through this statement and accompanying recommendations, ASCO hopes to increase awareness of the tremendous global impact of human papillomavirus (HPV) -caused cancers, refocus the discussion of HPV vaccination on its likely ability to prevent millions of cancer deaths, and increase HPV vaccination uptake via greater involvement of oncology professionals in ensuring accurate public discourse about HPV vaccination and calling for the implementation of concrete strategies to address barriers to vaccine access and acceptance.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1527-7755
1527-7755
DOI:10.1200/JCO.2016.67.2014